These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 11548660)

  • 21. HIV prevention and treatment in Africa.
    Laurence J
    AIDS Patient Care STDS; 2000 Aug; 14(8):399-400. PubMed ID: 10977967
    [No Abstract]   [Full Text] [Related]  

  • 22. 3 by 5 initiative: treating 3 million by 2005.
    East Mediterr Health J; 2002 Nov; 8(6):835-7. PubMed ID: 15568463
    [No Abstract]   [Full Text] [Related]  

  • 23. The cost of access to HIV treatment.
    Galatowitsch P; Siegfried N
    Science; 2006 Dec; 314(5805):1540-1; author reply 1540-1. PubMed ID: 17158305
    [No Abstract]   [Full Text] [Related]  

  • 24. Beyond Barcelona--the global response to HIV.
    Steinbrook R
    N Engl J Med; 2002 Aug; 347(8):553-4. PubMed ID: 12192013
    [No Abstract]   [Full Text] [Related]  

  • 25. Médecins Sans Frontières (MSF) antiretroviral treatment projects worldwide.
    GMHC Treat Issues; 2003; 17(7-8):7. PubMed ID: 14686313
    [No Abstract]   [Full Text] [Related]  

  • 26. CalPERS to reopen drug giant's AIDS drug-pricing issue.
    AIDS Policy Law; 2003 Dec; 18(22):9. PubMed ID: 14974405
    [No Abstract]   [Full Text] [Related]  

  • 27. The new Medicare drug plan: implications for people living with HIV/AIDS.
    HRSA Careaction; 2005 Oct; ():1-8. PubMed ID: 16479678
    [No Abstract]   [Full Text] [Related]  

  • 28. HIV services threatened by cutbacks and drug costs.
    Tighe A
    Nurs Stand; 2008 Jan 9-15; 22(18):33. PubMed ID: 18240803
    [No Abstract]   [Full Text] [Related]  

  • 29. Global. Creative approach allows MSF to treat children with AIDS.
    AIDS Policy Law; 2005 Aug; 20(15):9. PubMed ID: 16136688
    [No Abstract]   [Full Text] [Related]  

  • 30. Sustaining treatment costs: who will pay?
    Zewdie D; De Cock K; Piot P
    AIDS; 2007 Jul; 21 Suppl 4():S1-4. PubMed ID: 17620744
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinton Foundation negotiates $140/Year HIV treatment, but U.S. won't buy.
    James JS
    AIDS Treat News; 2004 Mar; (399):2-4. PubMed ID: 15199865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost imposes barrier to HIV treatment in Missouri.
    AIDS Policy Law; 2005 Jul; 20(13):2. PubMed ID: 16044518
    [No Abstract]   [Full Text] [Related]  

  • 33. Economic impact of HIV.
    Veenstra N; Whiteside A
    Best Pract Res Clin Obstet Gynaecol; 2005 Apr; 19(2):197-210. PubMed ID: 15778110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV/AIDS. Treatment and prevention exchange vows at international conference.
    Cohen J
    Science; 2008 Aug; 321(5891):902-3. PubMed ID: 18703717
    [No Abstract]   [Full Text] [Related]  

  • 35. Tripping over patents: AIDS, access to treatment and the manufacturing of scarcity.
    Berger JM
    Conn J Int Law; 2002; 17(2):157-248. PubMed ID: 12688292
    [No Abstract]   [Full Text] [Related]  

  • 36. World Trade Organization still threatens supply of affordable AIDS drugs.
    Hagmann M
    Bull World Health Organ; 2002; 80(9):762-3. PubMed ID: 12378300
    [No Abstract]   [Full Text] [Related]  

  • 37. Access for all?
    Lange JM; Thaineua V
    Science; 2004 Jun; 304(5679):1875. PubMed ID: 15218109
    [No Abstract]   [Full Text] [Related]  

  • 38. Africa activism: money for AIDS not for war; South Africa antiretrovirals.
    AIDS Treat News; 2003 Apr; (390):8. PubMed ID: 12739477
    [TBL] [Abstract][Full Text] [Related]  

  • 39. HIV/AIDS. The great funding surge.
    Cohen J
    Science; 2008 Jul; 321(5888):512-9. PubMed ID: 18653876
    [No Abstract]   [Full Text] [Related]  

  • 40. A remedy beyond lower cost drugs.
    Zuniga JM
    IAPAC Mon; 2001 Sep; 7(9):267. PubMed ID: 11708270
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.